Supplementary Data for Midkine in Meningioma: Single-Cell and Organoid Analysis

Supplementary Material 2 is a 344.0 KB XLSX file published on figshare by Pei-Ran Li in April 2026. The data likely contains tabular results supporting research on Midkine as a prognostic and therapeutic target in meningioma. The columns suggest findings from single-cell analysis and organoid-based drug validation experiments.

Use Cases

• Validate prognostic markers for meningioma patient stratification (inferred from domain, verify after download)
• Train models to predict drug response using organoid screening data (inferred from domain, verify after download)
• Analyze single-cell RNA sequencing results for target discovery (inferred from domain, verify after download)

Strengths

• Published on figshare under the CC-BY-4.0 license, allowing for open reuse.
• File format is XLSX, which is widely accessible for analysis.

Limitations

• Metadata is minimal; actual content requires verification after download.
• Row count and column definitions are unknown, which may limit suitability assessment.
• Data may reflect bias inherent to the specific experimental methods used.

Provenance

Source

figshare

Freshness

Last updated 2026-04-18 03:40:43.